Real-time enrollment status for this waldenstrom macroglobulinemia clinical trial
Current Status
Recruiting
Checked: March 2, 2026 at 11:51 AM UTC
| NCT Number | NCT06510491 |
| Recruiting Status | Recruiting |
| Condition | Waldenstrom Macroglobulinemia |
| Phase | Clinical Trial |
| Target Enrollment | 20 participants |
| Active Locations | 3 sites in the US |
| Sponsor | Gottfried von Keudell, MD PhD |
| Last Updated on CT.gov | December 17, 2024 (Dec 17, 2024) |
As of March 2, 2026: Clinical trial NCT06510491 is currently recruiting participants. This clinical trial study for waldenstrom macroglobulinemia is actively seeking new participants at 3 locations across the United States. The study is sponsored by Gottfried von Keudell, MD PhD. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06510491 is actively recruiting participants as of March 2, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 3 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06510491 was last updated Dec 17, 2024 (December 17, 2024). HelloStudys verifies this status automatically.